

Please try another search
PT Kalbe Farma Tbk is an Indonesia-based pharmaceutical company. The Company’s business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. It also offers a selection of non-milk nutritional products, such as Fitbar and Nutrive Benecol. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Name | Age | Since | Title |
---|---|---|---|
- Mulialie | - | 2021 | Director |
Jos Iwan Atmadjaja | 51 | 2021 | Director |
Sie Djohan | 54 | 2007 | Director of Corporate Business Development, Management System & Regulatory Affairs and Director |
Ferdinand B. Aryanto | 49 | 2008 | Commissioner |
Santoso Oen | 57 | 2000 | Commissioner |
Bernadus Karmin Winata | 57 | 2017 | Director |
Ronny Hadiana | 50 | 2015 | Commissioner |
Lucky Surjadi Slamet | 68 | 2014 | Independent Commissioner |
- Vidjongtius | 57 | 1997 | President Director |
Lilis Halim | 61 | 2019 | Independent Commissioner |
Adi Harsono | 66 | 2020 | Commissioner |
Bernadette Ruth Irawati Setiady | 59 | 1997 | President Commissioner |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review